auto_awesome
view_in_ar 3D Structure
science
Select a structure to view
LLM-agents & bio-AI models
What if an AI-agent could generate protein binders?
Combining two distinct areas of AI, the general LLM and the narrow specialized model. Prompt your own peptides with the help of an agent with expert level biological reasoning.
Lowering the bar for actual breakthroughs
A first-in-class example of complex coordination, bridging the areas of agentic reasoning and binder design.
database
Agentic research & tool use
Access the world's biomedical text data and millions of protein structures. Our agents access them all and deploy their advanced reasoning capabilites on them at scale, followed by intelligently zeroing in on relevant targets with applicable tools.
clinical_notes
Wet-lab validation
Models like Boltzgen and Drugclip are cutting-edge tools but of course need to be validated in the lab, soon fully autonomously.
groups
Custom synthesis
To continue your research, custom synthesis through our partners with delivery to your research facility.
Agent
Toolbox
Powered by state-of-the-art models
Our research agent autonomously selects and orchestrates the right tools for your task, from generative protein design to small molecule binding prediction.
-
check_circle
Boltzgen — Protein binder generation & optimization
-
check_circle
Drugclip — AI-driven virtual screening of 500 million compunds against 10 000 human proteins
-
check_circle
Drugable Agent — Wields powerful tools & knows how to use them
-
check_circle
CellType CLI — Biological reasoning & agentic research
agent_pipeline.log
search
Query: "Design a binder for PD-L1 ectodomain"
library_books
PubMed: Retrieved 12 relevant structures…
PMIDs: 34526721, 33245890, 35124567…
science
Drugclip: Screening 500 million compounds…
bolt
Boltzgen: Optimizing top 3 candidates…
check_circle
Done — 3 high-affinity binders generated
Best ΔG: -12.4 kcal/mol | RMSD: 0.8 Å
Agent Active
4 tools orchestrated
12.3s total execution
Explore
Trending biological targets
Curated from the latest PubMed and NCBI publications, start your research from the cutting edge.
Oncology
arrow_outward
KRAS G12C
Oncogenic driver mutation, major target for lung and colorectal cancers
article
2,847 papers (2025–25)
Immunology
arrow_outward
PD-L1 / PD-1
Immune checkpoint axis, backbone of cancer immunotherapy
article
5,120 papers (2025–25)
Signaling
pathway
arrow_outward
Wnt/β-catenin
Wnt/β-catenin, mechanism regulating development and cell proliferation.
article
3,215 papers (2025–25)
Metabolic
arrow_outward
GLP-1R
Glucagon-like peptide-1 receptor, revolutionary target for diabetes & obesity
article
4,692 papers (2025–25)
Cardiovascular
arrow_outward
PCSK9
Proprotein convertase, validated target for cardiovascular disease prevention
article
1,890 papers (2025–25)
Neurology
arrow_outward
TDP-43
RNA-binding protein, emerging target in ALS & frontotemporal dementia
article
1,456 papers (2025–25)
Oncology
arrow_outward
Bcl-2
B-cell lymphoma 2 is a gene that encodes a protein, which blocks apoptosis.
article
2,103 papers (2025–25)
Immuno-oncology
arrow_outward
CD47 / SIRPα
"Don't eat me" signal, innate immune checkpoint for hematological cancers
article
1,780 papers (2025–25)
shopping_cart_checkout
Synthesis Request
biotech
Your synthesis cart is empty.
Generate structures using BoltzGen or DrugClip to request quotes.
folder_special
